One can conclude that, (I) utilizing the immune activation properties of RT for the treatment of breast cancer, additional blocking of immune suppressive molecules such as PD-L1 is necessary, and that (II) hyperthermia (HT) might act as an additional immune stimulator. Here, CD274 is linked to breast carcinoma.